# WARD-Home - Continuous Monitoring of Vital Parameters After Discharge

> **NCT05223504** · — · COMPLETED · sponsor: **Rigshospitalet, Denmark** · enrollment: 80 (actual)

## Conditions studied

- Vital Sign
- Clinical Deterioration

## Interventions

- **DEVICE:** Continuously monitoring

## Key facts

- **NCT ID:** NCT05223504
- **Lead sponsor:** Rigshospitalet, Denmark
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-01
- **Primary completion:** 2022-06-15
- **Final completion:** 2022-06-15
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2022-06-28

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05223504

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05223504, "WARD-Home - Continuous Monitoring of Vital Parameters After Discharge". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT05223504. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*